Driven by the evidence, not by rhetoric or anecdote, we describe what the reality of research actually shows to be true.
Myth 1: Cancer is a man-made, modern disease
While it’s certainly true that global lifestyle-related diseases like cancer are on the rise, the biggest risk factor for cancer is age.
Myth 2: Superfoods prevent cancer
Blueberries, beetroot, broccoli, garlic, green tea… the list goes on. Despite thousands of websites claiming otherwise, there’s no such thing…
Cancer
Michael Coleman, professor at the London School of Hygiene and Tropical Medicine, and one of the lead authors of the study told TOI that one reason for the low survival rates in India could be that equitable access to early diagnosis and optimal treatment is not yet available for all people in India. "Some of the most advanced medical facilities in the world can be found in Mumbai (for example), but they are out of reach of the vast majority of the Indian population," he said. "The inequality…
Nine years later, against all odds, Mr. Telford is still alive. What saved him was an experimental immunotherapy drug—a medication that unleashes the body’s own immune system to attack cancer. His remarkable survival caught the attention of researchers, who began to realize that the way immunotherapy drugs were affecting tumors was unlike almost anything seen with conventional treatments. Today Mr. Telford is among a growing group of super-survivors who are transforming the world of…
The U.S. Food and Drug Administration (FDA) has approved CYRAMZA® (ramucirumab) in combination with paclitaxel (a type of chemotherapy) as a treatment for people with advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma whose cancer has progressed on or after prior fluoropyrimidine- or platinum-containing chemotherapy. CYRAMZA now has two FDA approvals for these patients. Today's announcement follows the April approval of CYRAMZA as a…
More than half of bladder cancers in the US are the result of smoking, and 90 per cent of smokers with the disease are aware of the connection, according to a new study. "Bladder cancer is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim. Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found…
Cancer Institute chairperson Dr V Shanta expressed concern over underreporting of cancer among children, especially in rural areas. Advances in oncology over the past six decades have ensured that up to 75 % of all paediatric cancers can be cured. While it is possible to treat all pediatric cases in the country, there is a need to increase affordability and accessibility for the same," she said. http://timesofindia.indiatimes.com/City/Chennai/Parents-deny-girls-cancer-treatment-say-doctors…
Women with breast cancer tumors that overexpress human epidermal growth factor receptor 2 (HER2) may benefit from a novel vaccine to prevent recurrence A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. One of only a few vaccines of its kind in development, GP2 has been shown to be safe and effective for breast cancer patients, reducing recurrence rates by 57%. Further, women with the highest overexpression…
Mayo Clinic unveiled today a partnership with IBM to harness the power of its Watson supercomputer to match patients with the right clinical trials. Starting early next year, Watson will initially enroll patients with breast, colorectal and lung cancers based on eligibility. There are 170,000 ongoing clinical trials around the world, however, according to the Center for Information and Study on Clinical Research Participation, only 6% are completed on time. Enrolling patients in the…
Clinical depression was much more prevalent among cancer patients than in the general population, where around 2% of people suffer from the mental illness at any point in time. Among cancer patients, clinical depression ranged from 13% in people with lung cancer to 6% in people with genitourinary cancer. The study's lead author Michael Sharpe, from Oxford University, said: "Major depression is really quite common in people with cancer and the perhaps surprising finding is that most of it goes…
